Clinical Trial

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2024 (before its estimated October 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study aims to discover novel biomarkers and therapeutic targets for osteoporosis through the use of advanced omics technologies, including proteomics and metabolomics. By analyzing bone and plasma samples from patients with osteoporosis, the research seeks to understand the underlying mechanisms of the disease and identify potential diagnostic and therapeutic biomarkers.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06525688
Lead Sponsor National and Kapodistrian University of Athens
Collaborators: National Hellenic Research Foundation
Conditions Osteoporosis, Postmenopausal, Osteoporosis Fracture, Osteoporosis, Severe
Enrollment 60 participants
Start Date 2024-07-03
Primary Completion 2024-10-15 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-29